Cargando…
Pulmonary Embolism in the Cancer Associated Thrombosis Landscape
In cancer patients, pulmonary embolism (PE) is the second leading cause of death after the cancer itself, most likely because of difficulties in diagnosing the disease due to its nonclassical presentation. The risk of PE recurrence and possibly the case-fatality rate depends on whether the patient p...
Autores principales: | Poenou, Géraldine, Dumitru Dumitru, Teona, Lafaie, Ludovic, Mismetti, Valentine, Ayoub, Elie, Duvillard, Cécile, Accassat, Sandrine, Mismetti, Patrick, Heestermans, Marco, Bertoletti, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570910/ https://www.ncbi.nlm.nih.gov/pubmed/36233519 http://dx.doi.org/10.3390/jcm11195650 |
Ejemplares similares
-
Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives
por: Poenou, Geraldine, et al.
Publicado: (2022) -
Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?
por: Poenou, Géraldine, et al.
Publicado: (2023) -
Cardiac Biomarkers in Patients with Acute Pulmonary Embolism
por: Janisset, Luc, et al.
Publicado: (2022) -
Management of Cancer-Associated Thrombosis in France: A National Survey among Vascular Disease and Supportive Care Specialists
por: Mahé, Isabelle, et al.
Publicado: (2022) -
Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications
por: Heestermans, Marco, et al.
Publicado: (2022)